行情

DNLI

DNLI

Denali
NASDAQ

实时行情|Nasdaq Last Sale

27.98
+3.33
+13.51%
盘后: 27.30 -0.68 -2.43% 17:48 01/27 EST
开盘
25.00
昨收
24.65
最高
30.41
最低
24.84
成交量
270.33万
成交额
--
52周最高
29.45
52周最低
14.24
市值
26.87亿
市盈率(TTM)
-41.0324
分时
5日
1月
3月
1年
5年

分析师评级

11位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

DNLI 新闻

  • 日本拟向中国赠送口罩和防护服等援助物资
  • 新浪财经.2小时前
  • Facebook和雷蛇限制员工赴中国旅行
  • 新浪财经.2小时前
  • 国际油价跌至去年10月以来新低 四天下跌9%
  • 新浪财经.3小时前
  • 将救命药提价55倍的“坏小子”史克莱利面临终身禁业
  • 新浪财经.3小时前

更多

所属板块

生物技术和医学研究
-0.88%
制药与医学研究
-0.51%

热门股票

名称
价格
涨跌幅

DNLI 简况

Denali Therapeutics Inc. is a biotechnology company. The Company is focused on the discovery and development of therapies for patients with neurodegenerative disease, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis (ALS) and others. The Company is developing a diversified portfolio of therapeutics, based on scientific insights into the genetic causes and biological processes underlying neurodegenerative disease. The Company has selected approximately four specific pathways that are implicated as triggers or effectors of neurodegeneration, including degenogenes (genes that cause neurodegenerative disease when mutated), defective intracellular trafficking, glial dysfunction and axon degeneration. The Company’s development programs include Lysosomal Function Pathway, Glial Biology Pathway, and Cellular Homeostasis Pathway. Its product pipeline includes drug candidates such as DNL201, DNL 151, ATV:aSyn, ETV:IDS, DNL747, and ATV:TREM2.
展开

Webull提供Denali Therapeutics Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。